We next built a random forest survival model (see Supplementary Figure S1) using the Oncotype DX score, patient race, age and chemotherapy status to model BCSS and capture non-linear relationships in our cohort of 49,443 stage I/II, ER+, HER2−, LN− breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.